Immunoglobulin treatment in primary antibody deficiency
Authors:
- L.J. Maarschalk-EllerbroekLML.J. Maarschalk-Ellerbroek
- I.M. HoepelmanIHI.M. Hoepelman
- P.M. EllerbroekPEP.M. Ellerbroek
- 1 May 2011
- journal article
- review article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 37 (5) , 396-404
Abstract
No abstract availableKeywords
This publication has 108 references indexed in Scilit:
- CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiencyJournal of Clinical Investigation, 2010
- CD20 deficiency in humans results in impaired T cell–independent antibody responsesJournal of Clinical Investigation, 2010
- Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic reviewClinical and Experimental Immunology, 2007
- Adverse reactions of prophylactic intravenous immunoglobulin infusions in Iranian patients with primary immunodeficiencyAnnals of Allergy, Asthma & Immunology, 2004
- Adverse Effects of Intravenous Immunoglobulin TherapyDrug Safety, 1999
- Preimmunization and postimmunization pneumococcal antibody titers in children with recurrent infectionsAnnals of Allergy, Asthma & Immunology, 1996
- An Immunodeficiency Characterized by Impaired Antibody Responses to PolysaccharidesNew England Journal of Medicine, 1987
- Anaphylactic Reactions after Gamma Globulin Administration in Patients with HypogammaglobulinemiaNew England Journal of Medicine, 1986
- Hypogammaglobulinaemia during pregnancy in identical twin sistersInternational Journal of Gynecology & Obstetrics, 1982
- Persistent and Fatal Central-Nervous-System ECHOvirus Infections in Patients with AgammaglobulinemiaNew England Journal of Medicine, 1977